Cargando…

Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer

Epithelial ovarian cancer (EOC) is one of the deadliest gynaecological malignancies. The late diagnosis is frequent due to the absence of specific symptomatology and the molecular complexity of the disease, which includes a high angiogenesis potential. The first-line treatment is based on optimal de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrido, Maritza P., Fredes, Allison N., Lobos-González, Lorena, Valenzuela-Valderrama, Manuel, Vera, Daniela B., Romero, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772950/ https://www.ncbi.nlm.nih.gov/pubmed/35052757 http://dx.doi.org/10.3390/biomedicines10010077

Ejemplares similares

Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer
por: Vera, Daniela B., et al.
Publicado: (2021)

NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells
por: Garrido, Maritza P., et al.
Publicado: (2020)

Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells
por: Garrido, Maritza P., et al.
Publicado: (2020)

NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE(2) Signaling Axis
por: Garrido, Maritza P., et al.
Publicado: (2019)

Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells
por: Garrido, Maritza P., et al.
Publicado: (2018)

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers
por: Garrido, Maritza P., et al.
Publicado: (2023)

Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
por: Alfaro, Ignacio, et al.
Publicado: (2023)

Lactadherin: From a Well-Known Breast Tumor Marker to a Possible Player in Extracellular Vesicle-Mediated Cancer Progression
por: Durán-Jara, Eduardo, et al.
Publicado: (2022)

Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer
por: Retamales-Ortega, Rocío, et al.
Publicado: (2017)

Antitumoral Activity of Leptocarpha rivularis Flower Extracts against Gastric Cancer Cells
por: Carrasco, Nicolás, et al.
Publicado: (2023)

Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis
por: Vera, Carolina, et al.
Publicado: (2014)

Alternative/complementary possibilities
por: Carli, C, et al.
Publicado: (2011)

Helicobacter pylori outer membrane vesicles induce astrocyte reactivity through nuclear factor-κappa B activation and cause neuronal damage in vivo in a murine model
por: Palacios, Esteban, et al.
Publicado: (2023)

Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?
por: Redman, C. W., et al.
Publicado: (1990)

Peptide Targeted Gold Nanoplatform Carrying miR-145 Induces Antitumoral Effects in Ovarian Cancer Cells
por: Salas-Huenuleo, Edison, et al.
Publicado: (2022)

Thoracic ultrasound: Possible complementary criteria for the assessment of pulmonary fibrosis
por: Trovato, Guglielmo M., et al.
Publicado: (2014)

Caveolin-1-Mediated Tumor Suppression Is Linked to Reduced HIF1α S-Nitrosylation and Transcriptional Activity in Hypoxia
por: Sanhueza, Carlos, et al.
Publicado: (2020)

Current Research on Complementary and Alternative Medicine in the Treatment of Premature Ovarian Failure: An Update Review
por: Li, Yue, et al.
Publicado: (2022)

Current state and future possibilities of ovarian tissue transplantation
por: Takae, Seido, et al.
Publicado: (2019)

NGF/TRKA Promotes ADAM17-Dependent Cleavage of P75 in Ovarian Cells: Elucidating a Pro-Tumoral Mechanism
por: Garrido, Maritza P., et al.
Publicado: (2022)

Progressive Resistance Training as Complementary Therapy for Polycystic Ovarian Syndrome
por: Kogure, Gislaine Satyko, et al.
Publicado: (2017)

Current complementary and alternative therapy forgastroesophageal reflux disease
por: Jiang, Dianxuan, et al.
Publicado: (2023)

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
por: Elit, Laurie, et al.
Publicado: (2013)

Extracellular vesicles from gastric epithelial GES-1 cells infected with Helicobacter pylori promote changes in recipient cells associated with malignancy
por: González, María Fernanda, et al.
Publicado: (2022)

Angiogenesis in Gynecological Cancers: Role of Neurotrophins
por: Garrido, Maritza P., et al.
Publicado: (2019)

Increases in norepinephrine release and ovarian cyst formation during ageing in the rat
por: Acuña, Eric, et al.
Publicado: (2009)

Cancer and Complementary Therapies: Current Trends in Survivors’ Interest and Use
por: Qureshi, Maryam, et al.
Publicado: (2018)

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
por: Gupta, Sudeep, et al.
Publicado: (2019)

The Treatment of Complementary and Alternative Medicine on Premature Ovarian Failure
por: Lin, Jing, et al.
Publicado: (2021)

The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma
por: Li, Long, et al.
Publicado: (2022)

Epithelial ovarian cancer risk: A review of the current genetic landscape
por: Flaum, Nicola, et al.
Publicado: (2019)

Complementary expression of EphA7 and SCO-spondin during posterior commissure development
por: Stanic, Karen, et al.
Publicado: (2014)

Galectin-3: a possible complementary marker to the PSA blood test
por: Balan, Vitaly, et al.
Publicado: (2013)

Acute Abdomen Secondary to Ruptured Epithelial Ovarian Cancer during Pregnancy: The Relevance of Teamwork
por: Ortiz-Mendoza, Carlos Manuel, et al.
Publicado: (2017)

c-MYC and Epithelial Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2021)

Targeted Therapies in Epithelial Ovarian Cancer
por: Barrena Medel, Nicanor I., et al.
Publicado: (2010)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2013)

Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
por: Tymon-Rosario, Joan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g3hki73s554nl306r3je8k176r